| Getty Images Key Takeaways Moderna’s stock dropped slightly in early November when it released disappointing financial results for the third quarter of 2022. The company had to slash its original fu...
Tag: stephane bancel
Not Your Hot-Tip-From-Your-Brother-In-Law Biotech Stock
Better-than-expected Covid-19 vaccine sales pushed Moderna past Wall Street’s 2022 second-quarter … [+] forecasts. The company said Wednesday, Aug. 3, 2022, that its Spikevax vaccine brought in ...
Moderna’s Booster Shot Targeting Omicron And Original Strain Could Be Available Late Summer After Promising Trials
Topline Moderna is hoping to launch a new Covid booster shot this Fall that targets both the original coronavirus strain and omicron variant after promising early results from clinical trials, the com...
Moderna Stock Falls Despite Vaccine Sales More Than Tripling From Last Year
Topline Shares of Moderna dropped on Wednesday even after the biotech company reported higher-than-expected revenue and profits in the first quarter, with results boosted by soaring coronavirus vaccin...
Losses Top $130 Billion After Scientists Find Covid Boosters Aren’t Halting Omicron Infections
Topline Battered by a steep broad-market selloff this week, Moderna shares fell for a sixth-straight day Friday as experts questioned whether Covid-19 vaccine sales alone will help justify the firm...